Botanical species · safety record

Lindera aggregata

The EFSA Compendium of Botanicals holds 6 constituent measurements for Lindera aggregata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lindera aggregata (Sims) Kosterm.

6Constituent measurements

0Safety records

5Cited sources

131Licensed products (Canada)

Also recorded as

Lindera strychnifolia (Siebold & Zucc.) Fern.-Vill.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 131 licensed products naming Lindera aggregata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA

Source material stated

New material
Radix
Root
Root and Rhizome
Root tuber(s)
Tuber
Whole plant
Whole plant(s)

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Norisoboldine	Roots and other underground parts	—	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Aporphine alkaloids	Roots and other underground parts	—	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Isoquinoline alkaloids	Roots and other underground parts	—	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Launobine	Roots and other underground parts	Solvent extraction	30 Milligram/kilogram	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Sesquiterpene lactones	Unspecified	—	—	Unspecified	No resolvable identifier
Tannins	Stem / stalk	Solvent extraction	—	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Gan, Li-She., Yao, Wei., Mo, Jian-Xia., Zhou, Chang-Xin. Alkaloids from Lindera aggregata. Natural product communications, 2009, vol. 4, no. 1, p. 43-46.
Zhang, Chao-Feng., Chou, Gui-Xin., Sun, Qi-Shi., Wang, Zheng-Tao., Hattori, Masao. Tannins from the stems of Lindera aggregata I. Zhongguo tianran yaowu, 2003, p. 204-206.
Tomita, Masao., Sawada, Tokunosuke., Kozuka, Mutsuo., Hamano, Daisuke., Yoshimura, Katsumi. Alkaloids of Lindera strychnifolia and Lindera umbellata. Yakugaku zasshi, 1969, p. 737-740.
Yan, Lili., Wang, Jinfang., Li, Qiuyue., Shi, Yue. Study of chemical components of Lindera aggregata. Zhongguo yaoye, 2013, p. 16-17.
Luo, Yubin., Liu, Mei., Dai, Yue., Yao, Xiujuan., Xia, Yufeng., Chou, Guixin., Wang, Zhengtao. Norisoboldine Inhibits the Production of Pro-inflammatory Cytokines in Lipopolysaccharide-Stimulated RAW 264.7 Cells by Down-Regulating the Activation of MAPKs but Not NF-kappa B . Inflammation, 2010, vol. 33, no. 6, p. 389-397. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature